Liothyronine Sodium

NuCare Pharmaceuticals,Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 12, 2024
Approval ID: 1133ebe8-38c2-2505-e063-6294a90aaa2f
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956

Quick Stats

Total Products1

Labelers2

Label Sections35

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.